Market Overview

Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc

Share:
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Related GILD
Stocks Hitting 52-Week Lows
Endeavor Funds' Jerome Dodson Defends 3 Stocks Beaten Down In 2016
Cardinal Health Has My Attention (Seeking Alpha)
Related C
Technical Alert: Citgroup Reaches $60 Since For First Time Since January 2009
Barron's Picks And Pans: 2017 Picks, Retail Stocks, AT&T And More
Citigroup: Primed For A Breakout? (Seeking Alpha)

On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.

Posted-In: Jim CramerBiotech CNBC Long Ideas Jim Cramer Media Trading Ideas General

 

Related Articles (GILD + C)

View Comments and Join the Discussion!